How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID)
Conclusions
Our study suggests differential access to key primary and secondary STI/HIV prevention interventions continued during the first year of the COVID-19 pandemic. However, there was not strong evidence that differential access has changed during the pandemic when compared with 2010–2012. While the pandemic might not have exacerbated inequalities in access to primary and secondary prevention, it is clear that large inequalities persisted, typically among those at greatest STI/HIV risk.
Source: Sexually Transmitted Infections - Category: Sexual Medicine Authors: Dema, E., Sonnenberg, P., Gibbs, J., Conolly, A., Willis, M., Riddell, J., Boso Perez, R., Copas, A. J., Tanton, C., Bonell, C., Oeser, C., Clifton, S., Unemo, M., Mercer, C. H., Mitchell, K. R., Field, N. Tags: Open access, COVID-19 Original research Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Chlamydia | COVID-19 | Pandemics | Sexual Medicine | Smokers | STDs | Study | UK Health | Women